Stroke Trial, Recruiting NCT07253870 Sponsor: Lahore University of Biological and Applied Sciences Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07253870
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had their first ever ischemic stroke (a stroke caused by a blocked blood vessel)
  • People who are in the subacute phase of recovery, meaning 3 to 6 months have passed since their stroke occurred
  • People whose arm and hand movement ability falls within a specific range on a standardised assessment scale called the Fugl-Meyer Assessment-Upper Extremity, with scores between 20 and 50 (confirm with trial site)

Who may not be able to join:

  • People who have had a previous injury to, or surgery involving, the vagus nerve (a major nerve running from the brain through the neck and chest)
  • People who have a history of cardiac arrest or irregular heart rhythms
  • People whose high blood pressure is not well controlled
  • People who have apraxia (a condition affecting the ability to carry out planned movements)
  • People who have other neurological conditions (affecting the brain or nervous system) or musculoskeletal conditions (affecting muscles, bones, or joints)
  • People who have an electronic medical device implanted in their body, such as a pacemaker

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Aruba Saeed, Lahore University of Biological and Applied Sciences

Phone: +92266303005

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Lahore University of Biological and Applied Sciences
Registry
ClinicalTrials.gov
Start date
20 November 2025
Est. completion
20 June 2026

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Fugl-meyer assessment of upper limb (FMA-UE); Montreal cognitive assessment (MoCA); Wolf Motor Function Test (WMFT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov